Filter Results:
(2,365)
Show Results For
- All HBS Web
(5,093)
- People (17)
- News (1,945)
- Research (2,365)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,858)
Show Results For
- All HBS Web
(5,093)
- People (17)
- News (1,945)
- Research (2,365)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,858)
Sort by
- 21 Apr 2020
- Research & Ideas
7 Successful Battle Strategies to Beat COVID-19
teams in territory that models cannot predict. COVID-19 events deliver surprises daily to many organizations, from health care specialists to government officials. The decision-making process that responds... View Details
Keywords: by Euvin Naidoo
- 03 Apr 2018
- First Look
New Research and Ideas, April 3, 2018
of spending on traditional aid programs in areas such as health care and food access in developing countries, GiveDirectly transfers cash directly to the poor. As experiments have shown this approach to be... View Details
Keywords: Sean Silverthorne
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
R&D-intensive firms react to negative shocks to their existing products? We explore this question using detailed project-level data from drug development firms. Using FDA Public Health Advisories as an exogenous and idiosyncratic... View Details
Keywords: Dina Gerdeman
- 15 Dec 2009
- First Look
First Look: Dec. 15, 2009
Publication:Academic Medicine 84, no. 12 (December 2009): 1663-1671 Abstract Recent focus on the need to improve the quality and safety of health care has created new challenges for academic View Details
Keywords: Martha Lagace
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
December 2017 Journal of Creative Behavior In Pursuit of Everyday Creativity By: Amabile, Teresa M. Abstract—Creativity researchers have long paid careful attention to individual creativity, beginning with studies of well-known geniuses... View Details
Keywords: Sean Silverthorne
- 2021
- Working Paper
Regulatory Approval and Expanded Market Size
By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite
Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details
Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry
Berger, Benjamin, Amitabh Chandra, and Craig Garthwaite. "Regulatory Approval and Expanded Market Size." NBER Working Paper Series, No. 28889, June 2021.
- 2025
- Working Paper
Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how efforts on multiple fronts, including advocacy, training, and technological development, made ultrasound the second most commonly used diagnostic imaging technology (after X-rays). Specifically, we chronicle 1) ultrasound’s development... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-003, July 2019. (Revised January 2025.)
- 29 Aug 2017
- First Look
First Look at New Research and Ideas, August 29
defining societal issue of the 21st century. The debate over “who gets what’ underlies policy debates ranging from taxation to health care to wages and permeates society at all levels, attracting increasing... View Details
Keywords: Sean Silverthorne
- 05 Sep 2012
- First Look
First Look: September 5
http://www.hbs.edu/research/pdf/12-064.pdf Cases & Course MaterialsPerformance Management at Vitality Health Enterprises, Inc. John B. Bingham and Michael BeerHarvard Business School Case 913-501 Vitality View Details
Keywords: Sean Silverthorne
- 14 Jan 2014
- First Look
First Look: January 14
treated and discharged at a faster rate in the dedicated queuing system than in the pooled queuing system. We conduct additional analyses to rule out alternate explanations, such as stinting on care and decreased quality of care. Our... View Details
Keywords: Sean Silverthorne
- 20 Sep 2011
- First Look
First Look: September 20
Hospital: Cardiac Care for the Poor (B) Tarun Khanna and Tanya BijlaniHarvard Business School Supplement 712-402 Narayana Hrudayalaya (NH) has expanded into a multi-specialty health city in Bangalore and has... View Details
Keywords: Sean Silverthorne
- 05 Nov 2021
- Op-Ed
How to Tap the Talent Automated HR Platforms Miss
As the global staffing shortage grinds on, corporate recruiters everywhere are relying on their online hiring platforms and automated systems to deliver the candidates they need. Too often, these tools will fail them, sidelining many qualified workers in the process.... View Details
Keywords: by Joseph B. Fuller
- 15 Apr 2014
- First Look
First Look: April 15
states as a consequence of changes in fiscal institutions and their interaction with colonial institutions. Working Papers Corporate and Integrated Reporting: A Functional Perspective By: Eccles, Robert, and George Serafeim Abstract—In this paper, we present the two... View Details
Keywords: Sean Silverthorne
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (B)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details
Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Pharmaceutical Industry; Biotechnology Industry; Switzerland; Europe
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono." Harvard Business School Case 396-035, September 1995.
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
capital and an end to predatory lending practices? Organizations lament sky-rocketing health care costs, but why is there such a limited effort to organize preventative care? Cutting Medicare will not stop... View Details
- 17 Oct 2012
- Research & Ideas
America Needs a Manufacturing Renaissance
community resource because it nourished the livestock that provided a foundation for the local agricultural economy. If the commons fell into disrepair—either through overuse or neglect—everyone suffered. Although taking care of the... View Details
- 18 Dec 2012
- First Look
First Look: December 18
their propensity to make things themselves (Experiments 3A and 3B). Paper: http://www.people.hbs.edu/mnorton/mochon norton ariely 2012.pdf Measuring Teamwork in Health Care Settings: A Review of Survey... View Details
Keywords: Carmen Nobel
- March 2017
- Case
Cantel Medical
By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details
Keywords: Cantel; Charles Diker; Furniture Industry; Matrix Organization; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Units; Business Growth and Maturation; Business Organization; For-Profit Firms; Chemicals; Profit; Revenue; Geographic Scope; Multinational Firms and Management; Health; Health Care and Treatment; Business History; Business or Company Management; Goals and Objectives; Growth and Development Strategy; Organizational Structure; Problems and Challenges; Research and Development; Opportunities; Strategy; Adaptation; Business Strategy; Competitive Strategy; Corporate Strategy; Diversification; Expansion; Information Technology; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States; New Jersey
Wells, John R., and Gabriel Ellsworth. "Cantel Medical." Harvard Business School Case 717-482, March 2017.
- 16 Feb 2016
- First Look
February 16, 2016
https://cb.hbsp.harvard.edu/cbmp/product/516027-PDF-ENG Harvard Business School Case 816-060 athenahealth's More Disruption Please Program No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816060-PDF-ENG Harvard Business School Case... View Details
Keywords: Sean Silverthorne